440 related articles for article (PubMed ID: 7936651)
1. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
[TBL] [Abstract][Full Text] [Related]
2. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J
Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
4. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
5. [Germline mutations of the p53 gene].
Frebourg T
Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
[TBL] [Abstract][Full Text] [Related]
7. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
Law JC; Strong LC; Chidambaram A; Ferrell RE
Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
[TBL] [Abstract][Full Text] [Related]
8. Three germline mutations in the TP53 gene.
Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
[TBL] [Abstract][Full Text] [Related]
9. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
[TBL] [Abstract][Full Text] [Related]
10. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S
Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321
[TBL] [Abstract][Full Text] [Related]
11. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
[TBL] [Abstract][Full Text] [Related]
12. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
Kovar H; Auinger A; Jug G; Müller T; Pillwein K
Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.
Davison TS; Yin P; Nie E; Kay C; Arrowsmith CH
Oncogene; 1998 Aug; 17(5):651-6. PubMed ID: 9704931
[TBL] [Abstract][Full Text] [Related]
14. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.
Srivastava S; Wang S; Tong YA; Pirollo K; Chang EH
Oncogene; 1993 Sep; 8(9):2449-56. PubMed ID: 8361758
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
[TBL] [Abstract][Full Text] [Related]
16. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
Evans SC; Lozano G
Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the TP53 gene.
Eeles RA
Cancer Surv; 1995; 25():101-24. PubMed ID: 8718514
[TBL] [Abstract][Full Text] [Related]
18. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
[TBL] [Abstract][Full Text] [Related]
19. A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.
Varley JM; McGown G; Thorncroft M; Cochrane S; Morrison P; Woll P; Kelsey AM; Mitchell EL; Boyle J; Birch JM; Evans DG
Oncogene; 1996 Jun; 12(11):2437-42. PubMed ID: 8649785
[TBL] [Abstract][Full Text] [Related]
20. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]